Grand Rounds by OncoDaily: AI in Oncology Edition

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

The Global Impact of URO-ONCO 2026

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Oncology News, Insights, Stories by OncoDaily

FDA Approves T-DXd
Breast Oncology

FDA Approves T-DXd for Two Early HER2-Positive Breast Cancer Settings

OncoDaily RT, Radiotherapy
Voices

OncoDaily Family is Growing: Launching Our New Radiotherapy Platform

FDA Approved Atezo
FDA Approvals

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

The Cancer Planners Forum Successfully Concluded in Geneva - UICC

EXTEND Trial Links ctDNA Clearance to Improved Outcomes After Radiotherapy

ASCO President Eric Small Honors The Impact of Volunteers

Top Early Phase Hematologic Oncology Trials to Watch at EHA 2026

Bristol Myers Squibb and Hengrui Forge $15.2 Billion Strategic Alliance, Reshaping China-Out Licensing Landscape

Isabel Mestres: C/Can and MSD Launch $10 Million Partnership for Women Living With Cancer

Tom Powles: VOLGA Trial Shows Survival Improvements of EV and Durvalumab in Bladder Cancer

Voices
Arnaud Delhaye

Arnaud Delhaye: Helping Define the Future of Radiation Medicine at ESTRO 2026

Robert Stone: Convening National Leaders to Explore the Intersection of Microbiome, Nutrition, and Cancer Care

Jean-Charles Soria: Liquid Biopsy Can Now Profile the Tumor Microenvironment

Andrea Ziblat: Excited to Be Selected as an Abstract Reviewer for SITC 2026

What Does Truly Patient-Centred Childhood Cancer Care Look Like? - Childhood Cancer International

Catherine Alix-Panabières: Celebrating 65 years of Friendship and Cooperation Between Montpellier and Heidelberg 

When Gold Mining Poisons Rivers, Who Pays the Price? - Global Health Otherwise

FDA Approvals
FDA Approved Atezo

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

2026 Memorial Sloan Kettering Cardio-Oncology Symposium

Memorial Sloan Kettering Cancer Center

21 May
Cardio-Oncology

Geriatric Oncology: Cognition and Communication 2026 - MSKCC

Memorial Sloan Kettering Cancer Center

28 May
Geriatric Oncology

MASCC Webinar - The Hidden Burden: Understanding and Treating Cancer Fatigue

MASCC

21 May
Cancer Fatigue

2nd International Conference on Cancer Research and Immuno-Oncology

Researchers Fusion

30 May
Immuno-Oncology

C2S Study: “Surviving Cancer in India: Giant Leaps For Humankind" - Resonance

Resonance

29 May
C2S Study

Immune-oncology
Short-Term Fasting Enhances Immunotherapy Response

Short-Term Fasting Enhances Immunotherapy Response

CheckMate 73L: Nivolumab Plus Chemoradiotherapy for Stage III NSCLC

DRUN Trial: Docetaxel Plus Ramucirumab After Immunotherapy in Advanced NSCLC

Could Morning Immunotherapy Become the New Standard in HCC?

10 Must-Read Posts in Immuno-Oncology This Week

TAPUR Study: Nivolumab Plus Ipilimumab in High TMB Solid Tumors

NEOSUMMIT-01 Trial: Perioperative Toripalimab in Locally Advanced Gastric or Gastroesophageal Junction Cancer

Gastrointestinal-Oncology
POD1UM-303/InterAACT-2

POD1UM-303/InterAACT-2 Trial: Retifanlimab plus Chemo in 1L Advanced Squamous Anal Cancer

Sintilimab Plus Lenvatinib Followed by Surgery in Unresectable HCC

Phase 2 nITRO Trial: Perioperative NALIRIFOX in resectable PDAC

FLOWER Study: Trifluridine/tipiracil Plus Bevacizumab in Later-Line mCRC

10 Must-Read Posts In GI Oncology This Week

FDA Approved Zenocutuzumab-zbco for Advanced NRG1 Fusion-Positive Cholangiocarcinoma

Daraxonrasib Shows Antitumor Activity in Previously Treated RAS-Mutated Pancreatic Cancer

Breast-Oncology
FDA Approves T-DXd

FDA Approves T-DXd for Two Early HER2-Positive Breast Cancer Settings

Metastatic Breast Cancer: Liquid Biopsy Reveals an Immunovascular Signature

GLP-1 Receptor Agonists Show a Striking Signal in Breast Cancer Outcomes, but Big Questions Remain

INAVO120: Inavolisib Benefit Persisted With or Without Hyperglycemia in PIK3CA-Mutated Advanced Breast Cancer

ESMO Breast Cancer 2026: What You Should Not Miss

SATEEN Trial at ESMO Breast Cancer Annual Congress 2026: A Limited Activity of SG Plus Trastuzumab After T-DXd in HER2+ MBC

HER2CLIMB-02 Trial at ESMO Breast Cancer Annual Congress 2026: Tucatinib Plus T-DM1 Maintains PFS Benefit Without OS Improvement

Lung-Oncology
Pembrolizumab

5 Powerful Findings on Pembrolizumab Dosing in NSCLC

Nearly Half of Older Adults With Metastatic NSCLC Never Received Systemic Therapy

ZNF683+ CD8+ T Cells and SPP1 Signaling May Define Immunotherapy Response in NSCLC

Early Pembrolizumab Plasma Level May Predict Survival in Metastatic NSCLC

ICARUS-LUNG01 Reveals Biomarkers of Response and Resistance to Dato-DXd in Advanced NSCLC

MARIPOSA: Amivantamab Plus Lazertinib Reduces EGFR/MET Resistance and Extends Second-Line Disease Control in EGFR-Mutated NSCLC

FRONT-BRAF: Should Immunotherapy Come First in BRAF V600E-Mutated Metastatic NSCLC?

OncoDaily TV
Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Hisham Mehanna

What It Takes to Lead in Oncology Prof. Hisham Mehanna on Research, Mentorship & Life Balance

ASCO

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

Lucica Ditiu

Ending Tuberculosis by 2030: Is It Still Possible? | Dr Lucica Ditiu

City-Level Cancer Care: A Missing Piece in the Puzzle?

City-Level Cancer Care: A Missing Piece in the Puzzle?

Empowering Oncologists: Why Survivorship Matters?

Empowering Oncologists: Why Survivorship Matters?

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

European Conference on Interventional Oncology Jean Palussière

Highlights from The European Conference on Interventional Oncology ECIO 2026

Journey from Botswana South Africa

A Journey from Botswana to the Frontlines of Global Health Leadership։ Shenaaz El Halabi

Giuseppe Caruso SGO 2026 Congress Highlights

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology – Key Takeaways with Giuseppe Caruso

Not To Miss
15 Posts Not To Miss From RomeLung26

15 Posts Not To Miss From RomeLung26

10 Must-Read Posts In GI Oncology This Week

World Melanoma Day Global Symposium: Key Highlights From a Global Melanoma Discussion

20 Posts Not To Miss From ESMO Breast Cancer Congress 2026

World Ovarian Cancer Day 2026: Raising Awareness on May 8

15 Posts Not To Miss From ASBrS2026

10 Must-Read Posts In GI Oncology This Week

OncoGrants
Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Pediatric Cancer Research Foundation (PCRF) — Emerging Investigator Fellowship Grant

Pediatric Cancer Research Foundation (PCRF) — Emerging Investigator Fellowship Grant

Alex's Lemonade Stand Foundation — 'A' Award Grant

Alex's Lemonade Stand Foundation — 'A' Award Grant

Alex's Lemonade Stand Foundation — R Accelerator Grant

Alex's Lemonade Stand Foundation — R Accelerator Grant

Alex's Lemonade Stand Foundation — Bio-Therapeutics Impact Grant

Alex's Lemonade Stand Foundation — Bio-Therapeutics Impact Grant

Cancer Research UK — Career Development Fellowship (Lung Cancer Priority Area)

Cancer Research UK — Career Development Fellowship (Lung Cancer Priority Area)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
CLL-RT

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

CancerWorld

Oncologists
Lillian Siu

Lillian Siu

Oncologists Location Toronto, Canada
Wang Xishan

Wang Xishan

Oncologists Location Beijing, China
Lynn Schuchter

Lynn Schuchter

Oncologists Location Philadelphia, USA
Tezer Kutluk

M. Tezer Kutluk

Oncologists Location Ankara, Türkiye
Douglas Flora

Douglas Flora

Oncologists Location Edgewood, USA
Ting Bao

Ting Bao

Oncologists Location Boston, USA
Hesham ElGhazaly

Hesham ElGhazaly

Oncologists Location Cairo, Egypt
Rony Dev

Rony Dev

Oncologists Location Houston, USA

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

PROOF 301

PROOF 301 Trial: Infigratinib vs Gemcitabine/Cisplatin in FGFR2-Rearranged Cholangiocarcinoma

OncoDaily Medical Journal

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research